Page last updated: 2024-10-20

pyridoxal phosphate and Achondroplasia

pyridoxal phosphate has been researched along with Achondroplasia in 1 studies

Pyridoxal Phosphate: This is the active form of VITAMIN B 6 serving as a coenzyme for synthesis of amino acids, neurotransmitters (serotonin, norepinephrine), sphingolipids, aminolevulinic acid. During transamination of amino acids, pyridoxal phosphate is transiently converted into pyridoxamine phosphate (PYRIDOXAMINE).
pyridoxal 5'-phosphate : The monophosphate ester obtained by condensation of phosphoric acid with the primary hydroxy group of pyridoxal.

Achondroplasia: An autosomal dominant disorder that is the most frequent form of short-limb dwarfism. Affected individuals exhibit short stature caused by rhizomelic shortening of the limbs, characteristic facies with frontal bossing and mid-face hypoplasia, exaggerated lumbar lordosis, limitation of elbow extension, GENU VARUM, and trident hand. (Online Mendelian Inheritance in Man, http://www.ncbi.nlm.nih.gov/Omim, MIM#100800, April 20, 2001)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Guzmán-Aránguez, A1
Crooke, A1
Yayon, A1
Pintor, J1

Other Studies

1 other study available for pyridoxal phosphate and Achondroplasia

ArticleYear
Effect of PPADS on achondroplasic chondrocytes: inhibition of FGF receptor type 3 over-activity.
    European journal of pharmacology, 2008, Apr-14, Volume: 584, Issue:1

    Topics: Achondroplasia; Animals; Cell Line; Cell Survival; Chondrocytes; Dose-Response Relationship, Drug; E

2008